Ernexa Therapeutics Inc. (ERNA): Nasdaq/NYSE listing notice — Eterna Therapeutics receives Nasdaq deficiency notice for insufficient stockholders' equity

Ernexa Therapeutics Inc.

Stockholders' equity ~$8.8M as of Sep 30, 2022, below $10M minimum for Nasdaq Global Market.
Company has 45 days to submit a compliance plan; Nasdaq may grant up to 180-day extension.
Company may also consider transferring its listing from Nasdaq Global Market to Nasdaq Capital Market.
Notice has no immediate effect on listing; delisting risk if compliance not regained within prescribed timeline.

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

Ernexa Therapeutics Inc. received a nasdaq deficiency notice notice regarding stockholders equity (rules 5450(b)(1)(A)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: stockholders equity
Rules: 5450(b)(1)(A)

Exact text from the filing

November 22, 2022, Eterna Therapeutics Inc. (the “ Company ”) received a notice (the “ Notice ”) from the Nasdaq Stock Market LLC (“ Nasdaq ”), stating that the Company’s stockholders’ equity of approximately $8.8 million, as reported in the Company’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2022, fails to comply with the minimum $10.0 million stockholders’ equity requirement for continued listing on the Nasdaq Global Market in accordance with Nasdaq Listing Rule 5450(b)(1)(A) (the “ Nasdaq Listing Rule ”). The Notice has no immediate effect on the listing of the Com

View on SEC.gov

Browse all listing & compliance notices →

Ernexa Therapeutics Inc. filing history →

Source: SEC EDGAR

accession 0001140361-22-042849

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.